MedPath

A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Colorectal Surgeries(SPiM-RWS-CR)

Completed
Conditions
Single-Port Colorectal Surgeries
Interventions
Procedure: procedure
Registration Number
NCT06141421
Lead Sponsor
Ruijin Hospital
Brief Summary

A real-world study to evaluate the clinical performance and safety of da Vinci SP Surgical System ("SP single-port robot" for short) for single-port robot-assisted colorectal surgeries in the real world, providing a real world evidence for clinical application of the product in the Chinese population.

English name: da Vinci SP Surgical System Model and specification: SP1098 Manufacturer: Intuitive Surgical, Inc.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  1. Subjects who have received or plan to receive colorectal surgeries with the SP single-port robot, such as low anterior resection of the rectum with or without total mesorectal excision; right hemicolectomy, left hemicolectomy and sigmoidectomy with or without transanal total mesocolic excision and central blood vessel ligation; and transanal minimally invasive surgery.
  2. Patients who voluntarily decide to participate in the study and sign the ICF (or exempt from signature of the ICF as approved by the EC).
Exclusion Criteria
  1. Patients with missing data on the primary endpoint in retrospective cases;
  2. Subjects having any contraindications of single-port robot surgery;
  3. The intraoperative anatomy determined that minimally invasive surgery was not suitable;
  4. Patients who are considered inappropriate to participate in this study by investigator.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
RWS study for SP CR Surgeries da Vinci SP Surgical System(SP1098)procedure-
Primary Outcome Measures
NameTimeMethod
Intraoperative conversion rateIntraoperative
The incidence of device-related or likely related complications of Clavien-Dindo classification grade III or higher at postoperative 30 days30 days
Secondary Outcome Measures
NameTimeMethod
Postoperative pain scorefollow-ups 1 day (24±4 h), 3 days (72±4 h) and 1 month (30±5 days) after the surgery.
Admission to ICU and ICU LOSDuring the follow-up 1 day before discharge
Urethral catheter indwelling durationin the follow-up 1 month after the surgery
Surgical durationIntraoperative
Length of stay (LOS)During the follow-up 1 day before discharge
Intraoperative bleeding volumeIntraoperative
The rate of intraoperative blood transfusionIntraoperative
Short-term recovery of functionsin the follow-up 1 month after the surgery

Trial Locations

Locations (1)

Ruijin Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath